乐观
$82.44
情景价格
$83.970
-2.343 (-2.79%)收盘时
Henry Schein, Inc. is a solutions company for health care professionals. Its segments consist of Global Distribution and Value-Added Services, Global Specialty Products and Global Technology. Global Distribution and Value-Added Services include distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other practice services. This segment also markets and sells, under its own corporate brand, a portfolio of consumable merchandise. Global Specialty Products includes manufacturing, marketing and sales of dental implant and biomaterial products; endodontic, orthodontic and orthopedic products and other health care-related products and services. Global Technology includes development and distribution of practice management software, e-services, and other products.
Henry Schein Inc is a good buy right now, with a current price of $86.38 and a forward P/E ratio of 14.81, indicating it is attractively valued compared to its earnings growth potential. The company reported a strong net income of $94 million for Q2 2026, which is an increase from $86 million in the same quarter last year, showcasing solid growth. However, the main risk is its debt to equity ratio, which has risen to 90.70%, indicating increasing leverage that could impact financial stability.
BTIG
$110
2026-08-19
BTIG
2026-08-19
目标价
$110
Barclays
$100
2026-08-06
Barclays
2026-08-06
目标价
$100
Mizuho
$86
2026-08-05
Mizuho
2026-08-05
目标价
$86
UBS
$94
2026-08-05
UBS
2026-08-05
目标价
$94
Barrington
$104
2026-08-05
Barrington
2026-08-05
目标价
$104
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

Henry Schein Appoints New CFO Emmanuel Caprais

Henry Schein Cares Celebrates 25 Years of Impact

Henry Schein to Present at Baird Global Healthcare Conference

Henry Schein, Inc. Q2 2026 Earnings Call Insights

Henry Schein Reports Second Quarter Earnings Growth
Henry Schein, Inc. is a solutions company for health care professionals. Its segments consist of Global Distribution and Value-Added Services, Global Specialty Products and Global Technology. Global Distribution and Value-Added Services include distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other practice services. This segment also markets and sells, under its own corporate brand, a portfolio of consumable merchandise. Global Specialty Products includes manufacturing, marketing and sales of dental implant and biomaterial products; endodontic, orthodontic and orthopedic products and other health care-related products and services. Global Technology includes development and distribution of practice management software, e-services, and other products. It operates in the Healthcare sector (WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & S industry).
Henry Schein Inc is a good buy right now, with a current price of $86.38 and a forward P/E ratio of 14.81, indicating it is attractively valued compared to its earnings growth potential. The company reported a strong net income of $94 million for Q2 2026, which is an increase from $86 million in the same quarter last year, showcasing solid growth. However, the main risk is its debt to equity ratio, which has risen to 90.70%, indicating increasing leverage that could impact financial stability.
16 analysts cover HSIC: 9 rate it Buy, 7 Hold and 0 Sell. The average price target is 76.78.
暂无帖子
注册或登录后参与讨论本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。